American College of Cardiology, cliexa Launch Innovative Health Monitoring Platform

The American College of Cardiology and cliexa, have collaborated through the ACC Innovation Program to launch a home health monitoring platform called cliexa-PULSE.

” cliexa-PULSE is a revolutionary app and platform that allows cardiovascular clinicians to gather information from their patients before and after visits to ensure well-being and help pivot care plans that are individually tailored to patient needs,” says Andrew M. Freeman, MD, FACC, a member of the ACC Innovation Program-cliexa Work Group. “Using the cliexa platform allows for easy EMR integration along with the ability to capture chronic care management codes resulting in efficient personalized care. Further, with the upcoming population health tool, I can follow my entire panel of patients and help those in need sooner.”

As a virtual health solution, cliexa-PULSE is designed for clinicians to track symptoms, medications, and daily activity for the management of atrial fibrillation (AFib), hypertension (HTN), congestive heart failure (CHF), and coronary artery disease (CAD). Along with remote check-in, cliexa-PULSE offers remote patient monitoring tailored to any clinical workflow and provides bulletproof compliance, documentation support and MIPS reporting metrics.

With ACC’s clinical guidance, cliexa focused on user experience, both from patient reporting and clinician population health perspectives, providing discrete data and reports real-time into the EMR systems.

Mehmet Kazgan, founder and CEO of cliexa, said, “With the clinical guidance from ACC we have been receiving while developing this platform, we have built a great foundation that can be iterated for other chronic conditions. The views and feedback from ACC’s experts in the design work group helped us further understand the real needs and challenges for cardiology patient monitoring.”

Learn more about improving care coordination and a strengthened clinician-patient partnership with ACC Innovation’s Co-developed Platform.

The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.

cliexa, a Colorado-based digital health company, acquired ProSkedge.com, an automated surgical scheduling platform. cliexa’s end-to-end virtual health platform offers integrated clinical intake, automated documentation and remote patient monitoring solutions tailored to practices in multiple-subspecialty settings. cliexa has partnered with American College of Cardiology co-developing cardiovascular home health monitoring solutions since 2018.

“With the acquisition of ProSkedge, cliexa’s focus on actionable, meaningful and impactful patient reported outcomes now extends to the pre-clinical care portion of healthcare delivery. The integration of scheduling care enhances the patient experience and removes historic hurdles.” – Dr. Gerald Maccioli, Chairman of Advisory Board at cliexa

ProSkedge has been designed and developed by Dr Lukasz Kowalczyk, practicing gastroenterologist with over 10 years of GI and procedure experience. ProSkedge simplifies, automates, and personalizes the scheduling process for clinics and patients. With this acquisition, cliexa-ProSkedge becomes a true end-to-end platform for clinics and health systems, offering solutions from onboarding to post-procedure monitoring to patients.

“Surgical care continues to grow at a high rate and COVID has pushed care out of hospitals and into higher value ASC’s. As cliexa enables the digital delivery of care across ambulatory clinic settings, ProSkedge adds that expertise into the ASC’s and the surgical space. cliexa now offers healthcare organizations a singular, comprehensive system for high value digital transformation across the entire patient journey.” said Dr. Kowalczyk, who is now a board member at cliexa and Chief Medical Officer for GI and Surgical Automation.

Dr. Kowalczyk added, “Colon cancer screening with colonoscopy is a great example of how we can improve the journey for the patient and practice.  New colon cancer screening guidelines drop the initial screening age to 45-49.  This patient demographic, consisting of about 20M people, has shown a higher demand to manage their healthcare through a digital medium like the cliexa-ProSkedge platform.”

Learn more at cliexa.com/ProSkedge

 

cliexa welcomes Dr Macciolli as chairman of advisory board

cliexa, Integrated Virtual Care Solutions, Announces the Appointment of Gerald Maccioli, MD, MBA, FCCM, FASA as Chairman of its Advisory Board.

Dr. Maccioli practiced anesthesiology and critical care medicine for over 27 years. He completed fellowship training in cardiothoracic anesthesiology and critical care medicine at Duke University following a residency in anesthesiology at the University of North Carolina at Chapel Hill and an internal medicine internship at the University of Oklahoma.

“We are honored to have Dr. Maccioli on board. There could not be a better time to engage with such a successful leader and clinician who will guide us to better develop cliexa focusing on quality and compliance.” said Mehmet Kazgan, Founder and CEO at cliexa.

Prior to joining Envision Healthcare, where he worked as Chief Quality Officer, Dr. Maccioli served as Director of the American Society of Anesthesiologists for North Carolina, President of the Society of Critical Care Anesthesiologists, and Chair of the ASA Section on Education and Research. He has served as the Chair of the American Medical Association (AMA) Committee of Innovators, playing an influential role in developing comprehensive, progressively responsible healthcare reform strategies. Dr. Maccioli also served as a member of the Quality Improvement Advisory Committee and the Committee on Practice Sustainability and Professional Satisfaction.

“Patient reported outcomes (PROMs) are now the ‘coin of the realm’.  Having been involved in healthcare quality reporting for nearly 30 years; cliexa brings not an evolutional product but a disruptive change to actionable, and meaningful PROMs.  I am both honored and excited to join the organization. “ said Dr. Maccioli.

Learn more about Dr. Maccioli’s vision for empowered patient data:

Link to blog: Quality Improvement during a Pandemic: How cliexa Empowers Actionable Data Delivery

 

Frontline health workers are battling not only a public health crisis, but also a workforce crisis. As nursing shortages rise across the country, the most vulnerable communities are hit hardest. These turbulent times have highlighted deep-rooted inequities in health for communities of color, amplifying structural social and economic factors that contribute to poor health outcomes.

Johnson & Johnson Impact Ventures and Village Capital has invited cliexa, alongside fellow health tech entrepreneurs, investors, and public health stakeholders for a virtual startup showcase where 12 startups will pitch their companies.

Learn more about the partnership and register to attend the Startup Showcase on November 12.

As of May 2020, we are proud to announce we have joined the StartUp Health Transformer Community. Joining over 325 global innovators in the healthcare space, StartUp Health organizes and invests in healthcare entrepreneurs in a worldwide community. As a leading healthcare venture fund, their unique approach to seed funding early-stage startups has established a diverse portfolio of entrepreneurs in all facets of health technology to achieve “moonshots.” These Health Moonshots aim to improve global healthcare, ranging from access to care to the ultimate goal of curing disease and cancer.

As their new portfolio company, we share their vision of tackling the access to care moonshot, as highlighted in the recent interview with our Founder & CEO, Mehmet Kazgan. StartUp Health allows cliexa to expand upon our Colorado reach to establish networks with other companies leading innovation in the healthcare industry nationwide. Our shared goal is to improve interoperability among each stakeholder in healthcare. Alongside StartUp Health, our digital screening, EMR integration, and remote monitoring paired with artificial intelligence (AI) will drive access to care regardless of patient’s demographics.

We are proud to join the global army of Health Transformers and are looking forward to the opportunities that will arise from this fruitful partnership.

Come check us out on our Company Profile for more information!